Drug class
Uroprotective thiol compound; detoxifying agent for oxazaphosphorine-derived urotoxic metabolites
Mechanism of action
The sulfhydryl group of mesna reacts chemically with urotoxic ifosfamide metabolites, particularly acrolein, in urine to form stable, less toxic thioether products, reducing haemorrhagic cystitis risk. It does not prevent other systemic toxicities of ifosfamide.
General use cases
- Prevention of ifosfamide-induced haemorrhagic cystitis in patients receiving ifosfamide; the administration schedule is tied to the ifosfamide regimen and product instructions
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
